全文获取类型
收费全文 | 18189篇 |
免费 | 1440篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 158篇 |
儿科学 | 491篇 |
妇产科学 | 433篇 |
基础医学 | 2471篇 |
口腔科学 | 418篇 |
临床医学 | 2075篇 |
内科学 | 3693篇 |
皮肤病学 | 293篇 |
神经病学 | 1459篇 |
特种医学 | 733篇 |
外国民族医学 | 17篇 |
外科学 | 2491篇 |
综合类 | 197篇 |
一般理论 | 32篇 |
预防医学 | 1832篇 |
眼科学 | 208篇 |
药学 | 1196篇 |
中国医学 | 28篇 |
肿瘤学 | 1459篇 |
出版年
2023年 | 134篇 |
2022年 | 189篇 |
2021年 | 445篇 |
2020年 | 251篇 |
2019年 | 428篇 |
2018年 | 499篇 |
2017年 | 306篇 |
2016年 | 365篇 |
2015年 | 387篇 |
2014年 | 510篇 |
2013年 | 708篇 |
2012年 | 962篇 |
2011年 | 1013篇 |
2010年 | 523篇 |
2009年 | 506篇 |
2008年 | 830篇 |
2007年 | 791篇 |
2006年 | 778篇 |
2005年 | 755篇 |
2004年 | 713篇 |
2003年 | 682篇 |
2002年 | 639篇 |
2001年 | 547篇 |
2000年 | 578篇 |
1999年 | 509篇 |
1998年 | 216篇 |
1997年 | 174篇 |
1996年 | 170篇 |
1995年 | 145篇 |
1994年 | 125篇 |
1993年 | 131篇 |
1992年 | 385篇 |
1991年 | 334篇 |
1990年 | 328篇 |
1989年 | 274篇 |
1988年 | 288篇 |
1987年 | 253篇 |
1986年 | 278篇 |
1985年 | 242篇 |
1984年 | 198篇 |
1983年 | 180篇 |
1982年 | 110篇 |
1981年 | 104篇 |
1980年 | 108篇 |
1979年 | 170篇 |
1978年 | 120篇 |
1977年 | 103篇 |
1974年 | 109篇 |
1973年 | 123篇 |
1971年 | 96篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Oliver G Lowry A Vernava A Hicks T Burnstein M Denstman F Fazio V Kerner B Moore R Peters W Ross T Senatore P Simmang C Wexner S Wong WD 《Diseases of the colon and rectum》2000,43(9):1194-1200
It should be recognized that these guidelines should not be deemed inclusive of all proper method of care or exclusive of methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific procedure must be made by the physician in light of all of the circumstances presented by the individual patient.Prepared by The Standards Task Force The American Society of Colon and Rectal Surgeons 相似文献
993.
Rheological properties of contraceptive gels 总被引:2,自引:0,他引:2
The rheological properties of 4 commercially available contraceptive drug delivery gels and their dilutions with a vaginal fluid simulant were measured. These properties govern the critical functions of spreading and retention of these gels over the vaginal surfaces. Measurements made on Conceptrol, KY Plus, Gynol II, and Advantage-S included stress growth, stress relaxation and residual stress, and the shear rate dependence of viscosity. All gels exhibited non-Newtonian behavior including shear thinning and viscoelasticity. Conceptrol and Gynol II had no residual stress, while both KY Plus and Advantage-S did. The gels differed in their response to dilution with vaginal fluid simulant. 相似文献
994.
995.
C. L. van der Wilt G. W. Visser B. J. Braakhuis R. Wedzinga P. Noordhuis K. Smid G. J. Peters 《British journal of cancer》1993,68(4):702-707
A class of new 5-fluorouracil (FU) analogues, the 5-fluoro-5,6-dihydro-6- alkoxy-uracils was synthesised with a modification at the 6-position of the pyrimidine ring. At this position the analogues have a hydroxy or alkoxy group of different chain lengths either in the cis- or trans-configuration. The antiproliferative effect of these compounds was tested on five cell lines of different origin. Generally, the analogues with a cis-configuration had a higher activity than those with a trans-configuration. The growth inhibitory effect of the compounds decreased with increasing alkoxy chain length, but the compound with a hydroxy group had the lowest growth inhibitory effect. One analogue, cis-5-F-5,6-dihydro-6-methoxy-uracil had a higher antiproliferative effect than FU in one of the cell lines. Effects on thymidylate synthase (TS), the possible target of these analogues, were evaluated by thymidine rescue of growth inhibition and incorporation of tritiated deoxyuridine (3H-UdR) into DNA. In solid tumour cell lines addition of TdR reversed the antiproliferative effect. Inhibition of TS in intact cells was determined by measuring 3H-UdR incorporation in two cell lines. The effect of cis-5-F-5,6-dihydro-6-methoxy-uracil on incorporation of 3H-UdR was 2- to 5-fold stronger than that of FU in both cell lines. All other compounds produced a higher 3H-UdR incorporation than FU both at equimolar and equi-toxic concentration. Concluding from these results we regard cis-5-F-5,6-dihydro-6-methoxy-uracil as the most promising FU analogue of this series, because of its higher antiproliferative activity than FU and marked inhibition of TS in intact cells. 相似文献
996.
997.
E. M. van Lie Peters D. C. Aronson V. Everts L. J. Dooren 《European journal of pediatrics》1993,152(10):818-821
In an attempt to stimulate bone resportion, a 10-week-old infant with malignant infantile osteopetrosis was treated with high doses of calcitriol, a potent bone resorption stimulatory agent, combined with a low calcium diet to prevent hypercalcaemia. Although calcitriol administration was initiated at this very young age, our patient did not show any clinical, radiological, or histological improvement. Despite reports of positive results of this treatment in the literature, our patient did not reveal any signs of bone resorption. She eventually died from the complications of osteopetrosis at the age of 6 months after 88 days of therapy. 相似文献
998.
999.
Tartour E Mehtali M Sastre-Garau X Joyeux I Mathiot C Pleau JM Squiban P Rochlitz C Courtney M Jantscheff P Herrmann R Pouillart P Fridman WH Dorval T 《British journal of cancer》2000,83(11):1454-1461
Various studies have emphasized an immunodepression state observed at the tumour site. To reverse this defect and based upon animal studies, we initiated a phase I clinical trial of gene therapy in which various doses of xenogeneic monkey fibroblasts (Vero cells) genetically engineered to produce human IL-2 were administered intratumorally in 8 patients with metastatic solid tumours. No severe adverse effect was observed in the 8 patients analysed during this clinical trial even in the highest dose (5 yen 107 cells) group. This absence of toxicity seems to be associated with rapid elimination of Vero-IL-2 cells from the organism. Indeed, exogenous IL-2 mRNA could no longer be detected in the peripheral whole blood 48 hours after Vero-IL-2 cell administration. In addition, we did not find any expression of exogenous IL-2 mRNA in post-therapeutic lesions removed 29 days after the start of therapy. A major finding of this trial concerns the two histological responses of two treated subcutaneous nodules not associated with an apparent clinical response. The relationship between local treatment and tumour regression was supported by replacement of tumour cells by inflammatory cells in regressing lesions and marked induction of T and natural killer cell derived cytokines (IL-2, IL-4, IFNg ...) in post-therapeutic lesions analysed 28 days after the start of Vero-IL-2 administration. Gene therapy using xenogeneic cells as vehicle may therefore present certain advantages over other vectors, such as its complete absence of toxicity. Furthermore, the in vivo biological effect of immunostimulatory genes, i.e IL-2-, may be potentiated by the xenogeneic rejection reaction. 相似文献
1000.
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients 总被引:24,自引:0,他引:24
Foekens JA Peters HA Look MP Portengen H Schmitt M Kramer MD Brünner N Jänicke F Meijer-van Gelder ME Henzen-Logmans SC van Putten WL Klijn JG 《Cancer research》2000,60(3):636-643
The antigen levels of components of the urokinase-type plasminogen activator (uPA) system of plasminogen activation are correlated with prognosis in several types of cancers, including breast cancer. In the present study involving 2780 patients with primary invasive breast cancer, we have evaluated the prognostic importance of the four major components of the uPA system [uPA, the receptor uPAR (CD87), and the inhibitors PAI-1 and PAI-2]. The antigen levels were determined by ELISA in cytosols prepared from primary breast tumors. The levels of the four factors significantly correlated with each other; the Spearman rank correlation coefficients (r(s)) ranged from 0.32 (between PAI-2 and PAI-1 or uPAR) to 0.59 (between uPA and PAI-1). The median duration of follow-up of patients still alive was 88 months. In the multivariate analyses for relapse-free survival (RFS) and overall survival (OS), we defined a basic model including age, menopausal status, tumor size and grade, lymph node status, adjuvant therapy, and steroid hormone receptor status. uPA, uPAR, PAI-1, and PAI-2 were considered as categorical variables, each with two cut points that were established by isotonic regression analysis. Compared with tumors with low levels, those with intermediate and high levels showed a relative hazard rate (RHR) and 95% confidence interval (95% CI) of 1.22 (1.02-1.45) and 1.69 (1.39-2.05) for uPA, and 1.32 (1.14-1.54) and 2.17 (1.74-2.70) for PAI-1, respectively, in multivariate analysis for RFS in all patients. Compared with tumors with high PAI-2 levels, those with intermediate and low levels showed a poor RFS with a RHR (95% CI) of 1.30 (1.14-1.48) and 1.76 (1.38-2.24), respectively. Similar results were obtained in the multivariate analysis for OS in all patients. Furthermore, uPA and PAI-1 were independent predictive factors of a poor RFS and OS in node-negative and node-positive patients. PAI-2 also added to the multivariate models for RFS in node-negative and node-positive patients, and in the analysis for OS in node-negative patients. uPAR did not further contribute to any of the multivariate models. A prognostic score was calculated based on the estimates from the final multivariate model for RFS. Using this score, the difference between the highest and lowest 10% risk groups was 66% in the analysis for RFS at 10 years and 61% in the analysis for OS. Moreover, separate prognostic scores were calculated for node-negative and node-positive patients. In the 10% highest risk groups, the proportion of disease-free patients was only 27 +/- 6% and 9 +/- 3% at 10 years for node-negative and node-positive patients, respectively. These proportions were 86 +/- 4% and 61 +/- 6% for the corresponding 10% lowest risk groups of relapse. We conclude that several components of the uPA system are potential predictors of RFS and OS in patients with primary invasive breast cancer. Knowledge of these factors could be helpful to assess the individual risk of patients, to select various types of adjuvant treatment and to identify patients who may benefit from targeted therapies that are currently being developed. 相似文献